Endocrine Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114.
J Clin Invest. 1972 Dec;51(12):3163-72. doi: 10.1172/JCI107143.
Antigenic recognition of four anti-bovine parathyroid hormone antisera was characterized by their reactivity with bovine hormonal fragments (1-34, 1-13, 14-34, 19-34, 53-84) and human hormone extracted from parathyroid adenomas. All antisera were found to have antibody populations which recognized more than one antigenic determinant and all antisera differed in their specificity and reactivity for the fragments of bovine hormone. By modification of two antisera, GP-1 and GP-133, by preincubation with excess concentrations of 1-34 or 53-84 fragments, antigenic recognition was restricted to defined regions of the hormonal sequence.When assays using these modified antisera were applied to the study of hormones extracted from glands, greater immunochemical similarities were seen between bovine and human parathyroid hormone using assays that were specific for the measurement of amino-terminal portions of the hormones than of the carboxy-terminal portions.When assays using these antisera were applied to the study of endogenous parathyroid hormone in human plasma, the immunoreactive hormone in the general circulation was shown to substantially lack an amino-terminal portion of the sequence of the intact hormone, including an antigenic determinant requiring all or some of the 14-19 region. This deletion accounts, at least in part, for the immunochemical heterogeneity of plasma parathyroid hormone in man. Radioimmunoassay of fractions of peripheral plasma subjected to gel filtration confirms that the dominant form of the immunoreactive hormone in the general circulation of man is a hormonal fragment that is totally devoid of amino-terminal reactivity. Because of this deletion, it can be concluded that most of the immunoreactive parathyroid hormone in the general circulation of man must be biologically inactive.
四种抗牛甲状旁腺激素抗血清的抗原识别特性是通过它们与牛激素片段(1-34、1-13、14-34、19-34、53-84)和从甲状旁腺腺瘤中提取的人激素的反应性来描述的。所有抗血清都发现具有识别多个抗原决定簇的抗体群体,并且所有抗血清在对牛激素片段的特异性和反应性方面存在差异。通过用过量浓度的 1-34 或 53-84 片段预孵育两种抗血清 GP-1 和 GP-133 来修饰,抗原识别被限制在激素序列的特定区域。当使用这些修饰的抗血清进行测定时,应用于从腺体中提取的激素的研究,使用专门测量激素氨基末端部分的测定法,观察到牛和人甲状旁腺激素之间的免疫化学相似性更大,而不是羧基末端部分。当使用这些抗血清进行测定时,应用于研究人血浆中的内源性甲状旁腺激素,结果表明,循环中的免疫反应性激素基本上缺乏完整激素序列的氨基末端部分,包括需要全部或部分 14-19 区域的抗原决定簇。这种缺失至少部分解释了人血浆甲状旁腺激素的免疫化学异质性。对凝胶过滤后外周血浆的分数进行放射免疫测定证实,在人循环中占优势的免疫反应性激素形式是一种完全缺乏氨基末端反应性的激素片段。由于这种缺失,可以得出结论,人循环中的大多数免疫反应性甲状旁腺激素必须是生物上无活性的。